Kymera Therapeutics (KYMR) Shares Issued (2020 - 2025)
Historic Shares Issued for Kymera Therapeutics (KYMR) over the last 6 years, with Q3 2025 value amounting to -$711000.0.
- Kymera Therapeutics' Shares Issued changed N/A to -$711000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $13.3 million, marking a year-over-year decrease of 7297.53%. This contributed to the annual value of $48.7 million for FY2024, which is 160419.58% up from last year.
- Kymera Therapeutics' Shares Issued amounted to -$711000.0 in Q3 2025.
- Kymera Therapeutics' Shares Issued's 5-year high stood at $48.7 million during Q1 2024, with a 5-year trough of -$711000.0 in Q3 2025.
- In the last 5 years, Kymera Therapeutics' Shares Issued had a median value of $1.1 million in 2021 and averaged $4.7 million.
- Its Shares Issued has fluctuated over the past 5 years, first surged by 317994.62% in 2024, then tumbled by 9890.23% in 2025.
- Kymera Therapeutics' Shares Issued (Quarter) stood at $1.8 million in 2021, then dropped by 22.41% to $1.4 million in 2022, then tumbled by 58.72% to $563000.0 in 2023, then skyrocketed by 8557.19% to $48.7 million in 2024, then crashed by 101.46% to -$711000.0 in 2025.
- Its last three reported values are -$711000.0 in Q3 2025, $13.5 million for Q2 2025, and $535000.0 during Q1 2025.